Subscribe to Get Prostate Cancer News

Us TOO Presents: Prostate Cancer Pathways

Video Recorded on October 12, 2019
In Detroit, MI
As a Featured Presentation at: Karmanos Cancer Institute Cancer Symposium 2019

With Presenting Experts:

  • Zachery Roger Reichert MD, PhD - Medical Oncologist
  • Shelley L. Imholte, PhD, LCSW, M.Ed. - Sexual Life Improvement
  • Bahaa S. Malaeb, MD, FACS - Associate Professor, Genitourinary Trauma and Reconstructive Surgery; Medical Director, Taubman Urology Ambulatory Care Unit, University of Michigan
  • Gary McClain PhD, LMHC, CEAP - Counselor

CLICK TIME FOR DIRECT LINK TO EACH SEGMENT BELOW

  • 0:01 Intro - Joel Nowak, Co-Founder Cancer ABCs
  • 1:41 About Prostate Cancer - Dr. Zachery Reichert
  • 3:06 Balance of Cancer Care - Risk and Benefit
  • 6:01 Prostate Cancer Phases
  • 6:13 Clinically Localized Disease
  • 6:35 Rising PSA, Biochemical Recurrent Prostate Cancer
  • 7:22 Metastatic Hormone/Castration-Sensitive Prostate Cancer (mHSPC)
  • 7:59 Non-Metastatic Hormone/Castration-Reistant Prostate Cancer (nmCRPC)
  • 9:03 Metastatic Hormone Resistant Disease (mcRPC) - Treatments 1 and 2
  • 10:51 Testosterone (the Fuel for Prostate Cancer)
  • 11:16 Low Testosterone
  • 13:19 Sexual Dysfunction, Importance of Communication
  • 15:00 Imaging and Scanning
  • 15:50 PSMA (Prostate Specific Membrane Antigen) Based PET Scan
  • 18:11 Clinically Localized Prostate Cancer
  • 18:22 Active Surveillance
  • 19:12 Surgery
  • 19:41 Radiation
  • 20:08 Rising PSA After Local Therapy - Biochemical Recurrence
  • 20:17 Monitoring
  • 20:27 Salvage Radiation
  • 20:37 Hormone Therapy
  • 20:50 Risk and Benefit of Monitoring and Hormone Therapy
  • 21:15 No Metastases, Low Testosterone, Hormone Resistance (nmCRPC) - Rising PSA
  • 21:31 Continue Testosterone Lowering Therapy
  • 21:59 Treatments (Enzalutamide, Apalutamide, Darolutamide)
  • 22:25 Metastases with Intact Testosterone (nHSPC)
  • 22:41 Start Testosterone Lowering Therapy
  • 23:02 Intensification Strategy (Docetaxel, Abiraterone, Apalutamide)
  • 23:31 New Metastases with Low Testosterone (mCRPC)
  • 23:47 Continue Testosterone Lowering Therapy
  • 23:55 Additional Treatment Options (Docetaxel, Cabazitaxel, Abiraterone, Prednisone, Enzalutamide, Radiation, Sipuleucel-T)
  • 24:57 Future - Prevision Medicine, PSMA Based Therapy
  • 27:00 Cancer is a Prairie, Not a Corn Field
  • 28:40 Discussion/Q&A from a Patient Perspective
  • 28:55 Shared Decision Making
  • 31:49 Monitoring
  • 33:57 Importance of Bone Health
  • 43:01 PSA and Immunotherapy
  • 46:06 Thanks to Sponsors - Chuck Strand, CEO of Us TOO International
  • 47:30 Panel Intro by Jim Schraidt, Chairman of the Board of Us TOO International
  • 50:17 Panel Introduction - Dr. Bahaa S. Malaeb, Gary McClain, Dr. Shelley L. Imholte
  • 51:15 Jim Schraidt's Story - Diagnosis, Depression, Support Group
  • 53:01 Gary McClain's Story - Background, Emotions Related to Diagnosis, Depression and Anxiety
  • 57:48 Gary McClain - Advice for the Newly Diagnosed on Symptoms of Depression
  • 59:09 Dr. Malaeb - Informed Patient Decisions, Treatment Options and Side Effects
  • 1:03:28 Dr. Imholte - Sexual Dysfuction
  • 1:06:39 Dr. Imholte - Recommendations for Couples on Communication, Titration
  • 1:10:48 Q&A
  • 1:10:57 How Can a Support Group Leader Help Men with Symptoms of Depression?
  • 1:15:15 What if diagnosed, with no symptoms, and you do nothing to treat to avoid side effects?
  • 1:21:10 Testosterone - Sexual Function and Effects of Hormone Treatment
  • 1:25:32 Risk Factors for and Contributors to Prostate Cancer
  • 1:28:03 Support to Address Fatigue, Deficiencies, Depression During Treatment

Thank You to Host: Karmanos Cancer Institute and Sponsors: Astellas, Pfizer Oncology, Janssen Oncology, Amgen, Clovis Oncology, Dendreon, Genomic Health, Timm Medical Technologies Inc., and Advanced Accelerator Applications.